Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number ...

Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in ...

WuXi AppTec has put its cell and gene therapy manufacturing unit WuXi Advanced Therapies, which operates four laboratories ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American ...

Here is the complete list of stocks exiting their IPO lock-in period between October 8, 2024, and December 31, 2024 ...

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US ...

Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.

Kirk Spano and Bhavneesh Sharma talk biotech, pharma, and why complete response letters are a good contrarian buying ...

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...